Skip to main content

Table 2 Hepatobiliary scintigraphy measurements at baseline and 3-month follow-up

From: Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients

   Baseline 3-month follow-up
Case   Liver (total) Liver (treated) Liver (non-treated) Liver (total) Liver (treated) Liver (non-treated)
1 Volume 2481 1845 636 1919 1357 562
% 100 74 26 100 71 29
cMUR 3.0 2.3 0.7 2.4 1.6 0.8
% 100 77 23 100 67 33
2 Volume 1396 1178 285 1111 855 256
% 100 84 16 100 77 23
cMUR 1.8 1.6 0.2 0.6 0.4 0.2
% 100 87 13 100 77 23
3 Volume 1288 881 407 1218 713 505
% 100 68 32 100 59 41
cMUR 2.2 1.5 0.7 1.8 0.8 1.0
% 100 70 30 100 43 57
  1. Volume (in mL); cMUR = BSA corrected 99mTc-mebrofenin uptake rate (in %/min/m2)